You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | ELISA |
|---|---|
| Application Notes |
Key Properties
−| Reactivity | Mouse |
|---|---|
| Sample Types | serum, plasma, tissue homogenates and other biological fluids |
| Assay Type | Sandwich |
| Assay Time | 3.5h |
| Range | 3.13-200 U/L |
| Sensitivity | 1.39U/L |
| Concentration | 200 U/L |
Procedure & Performance
−| Assay Principle | |
|---|---|
| Kit Components | |
| Reagent Preparation | |
| Assay Procedure | |
| Materials Required | |
| Precision | |
| Calculation of Results | |
| Curve Fitting Softwares |
Storage & Handling
−| Storage | Refer to the Storage Guidelines in the Manual |
|---|---|
| Expiration Date | Please enquire. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Mouse GOT2 ELISA Kit [orb409397]
Mouse
1.56 mIU/mL-100 mIU/mL
0.39 mIU/mL
24 T, 10 x 96 T, 5 x 96 T, 48 T, 96 TMouse AST(Aspartate Aminotransferase) Microsample ELISA Kit [orb2998987]
3.13-200 U/L
1.34 U/L
96 T, 48 T

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−Filter by Applications
Filter by Species
Lu Xue 1 2, Xiaolin Yu 1, Lijing Zhao 1 3, Aria Garrett 4, Daqing Wu 1 5, Hong Yan Liu 1 Targeted Delivery of AR-V7 siRNA with Bivalent PSMA Aptamers Effectively Suppresses the Growth of Enzalutamide-Resistant Prostate Cancer Mol Pharm, (2024)
Applications
Reactivity
Agata Tomaszewska 1 2, Bartłomiej Kost 3, Marek Brzeziński 3, Martyna Nowicka 4 5 6, Maja Krupa 4, Tomasz Rechciński 7, Łucja Balcerzak 8, Sława Glińska 8, Magdalena Chmiela 4, Agnieszka Krupa 9 Targeted and safe delivery of colchicine via polymeric nanocarriers for potential atherosclerosis therapy with in vitro and in vivo evaluation Sci Rep, (2025)
Applications
Reactivity




